USA - NASDAQ:CGTX - US19243B1026 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to CGTX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-08 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-06-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-08 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-21 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-02-26 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-12-19 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-12-19 | B. Riley Securities | Upgrade | Neutral -> Buy |
| 2024-12-19 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-15 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-31 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-06 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2024-08-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-30 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2024-07-02 | Rodman & Renshaw | Reiterate | Buy -> Buy |
| 2024-06-06 | Chardan Capital | Initiate | Buy |
| 2024-05-29 | HC Wainwright & Co. | Initiate | Buy |
| 2024-03-28 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2024-03-27 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-14 | Ladenburg Thalmann | Maintains | Buy -> Buy |
| 2023-05-09 | Oppenheimer | Reiterate | Outperform |
| 2023-03-24 | Oppenheimer | Reiterate | Outperform |
| 2022-09-29 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-04-22 | Ladenburg Thalmann | Initiate | Buy |
| 2021-11-03 | Oppenheimer | Initiate | Outperform |
10 analysts have analysed CGTX and the average price target is 3.32 USD. This implies a price increase of 99.7% is expected in the next year compared to the current price of 1.66.
The consensus rating for COGNITION THERAPEUTICS INC (CGTX) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering COGNITION THERAPEUTICS INC (CGTX) is 10.